Afya Limited (AFYA)
| Market Cap | 1.40B |
| Revenue (ttm) | 584.95M |
| Net Income (ttm) | 106.45M |
| Shares Out | 90.45M |
| EPS (ttm) | 1.17 |
| PE Ratio | 13.24 |
| Forward PE | 10.32 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 103,555 |
| Open | 15.30 |
| Previous Close | 15.24 |
| Day's Range | 15.19 - 15.74 |
| 52-Week Range | 14.52 - 22.48 |
| Beta | 0.90 |
| Analysts | Sell |
| Price Target | 19.38 (+25.03%) |
| Earnings Date | Nov 13, 2024 |
About AFYA
Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisti... [Read more]
Financial Performance
In 2023, Afya Limited's revenue was 2.88 billion, an increase of 23.48% compared to the previous year's 2.33 billion. Earnings were 386.32 million, an increase of 3.41%.
Financial numbers in BRL Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for AFYA stock is "Sell." The 12-month stock price forecast is $19.38, which is an increase of 25.03% from the latest price.
News
Afya Limited Announces Entering Into a Share Purchase Agreement for the Acquisition of Faculdade Única de Contagem
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced ...
Afya Continues To Be An Opportunity Even After Brazil's Depreciation
Afya's 3Q24 results showed 12% organic revenue growth and 16% overall growth, driven by the Unidom acquisition and strong performance in medical education and software segments. The company leveraged ...
Afya Limited Third Quarter and Nine Months 2024 Financial Results
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported t...
Afya Limited to Report Third Quarter and Nine Months 2024 Financial Results on November 13th
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced ...
Afya Limited to Host Afya Day 2024 on October 29th | Hybrid Event
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, today anno...
Afya Assumes a Voluntary Commitment to Free Health Consultations
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced ...
Afya Limited Announces MEC Decision on Medical Seats Reconsideration in Unigranrio
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, today anno...
Afya Secures Full Disbursement of R$500 Million From IFC to Support the Company's Expansion
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil announced t...
Afya: Q2 2024 Was Not Surprising, Still An Opportunity Despite New Info On Market Supply
Afya's Q2 2024 results showed stable operations with 14% revenue growth, driven by increased enrollment and tuition, and improved operating margins. A favorable Supreme Court ruling on medical seat op...
Afya Limited Announces Second-Quarter and First-Half 2024 Financial Results
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported t...
Afya Limited (AFYA) Q2 2024 Earnings Call Transcript
Afya Limited (NASDAQ:AFYA) Q2 2024 Earnings Conference Call August 14, 2024 5:00 PM ET Corporate Participants Renata Couto - Investor Relations Virgilio Gibbon - Chief Executive Officer Luis Andre Bl...
Afya Secures Loan of up to R$500 Million From IFC to Support the Company's Expansion
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil announced t...
Afya Limited Releases 2023 Sustainability Report
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34), the leading medical education group and medical practice solutions provider in Brazil, announces the release of its 2023 Su...
Afya Limited Announces Medical Seats Increase in UNIMA Alagoas
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, today anno...
LANDBRIDGE ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING AND CONCURRENT PRIVATE PLACEMENT AND FULL EXERCISE OF THE UNDERWRITERS' OPTION TO PURCHASE ADDITIONAL SHARES
HOUSTON--(BUSINESS WIRE)--LandBridge Company LLC (“LandBridge”) closed its initial public offering of 14,500,000 Class A shares representing limited liability company interests (“Class A shares”) at a...
Afya Limited Announces Closing of the Acquisition of Unidompedro and Faculdade Dom Luiz
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, in additio...
Afya Announces Changes to Its Board of Directors
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced ...
Afya's Results Are Improving And The Market Is Undervaluing It
Afya Limited reports strong 1Q24 results with revenue up 13%, adjusted EBITDA up 20%, and net income up 77%. The company increases its total approved seats to 2,500 through acquisitions and organic gr...
Afya Limited Announces Results of Annual General Meeting Held on June 5, 2024
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced ...
Afya Limited (the "Company") Notice of Annual General Meeting of the Company
NOVA LIMA, Brazil--(BUSINESS WIRE)--Notice is hereby given that an Annual General Meeting of the Company (the "AGM") will be held at the offices of Afya Participações S.A. (Nasdaq: AFYA; B3: A2FY34) (...
Afya Limited (AFYA) Q1 2024 Earnings Call Transcript
Afya Limited (NASDAQ:AFYA) Q1 2024 Earnings Conference Call May 9, 2024 5:00 PM ET Company Participants Renata Couto - IR Virgilio Gibbon - CEO Luis Andre Blanco - CFO Conference Call Participants Lu...
Afya Limited Announces First-Quarter 2024 Financial Results
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported t...
Afya Limited Announces Entering Into a Share Purchase Agreement for the Acquisition of Unidompedro and Faculdade Dom Luiz
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and digital health services provider in Brazil, announced tod...
AFYA: Mr Market Is Mistaken
The company's 2023 earnings and revenue were strong, but its stock price has declined significantly. The selloff is largely due to AFYA's declining revenue growth rates. Guidance is also soft, adding ...
Afya Is Performing Well And Is A Buy
Afya is one of the leading private medical education providers in Brazil. The company's model has several quality characteristics including high pricing power, and resiliency to economic cycles. Afya ...